Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JUERGENS

Showing results (641-650 of 662) with videos related to

Pageof 67
Sort By:
Oncotarget|October 29, 2013
Alterations of immune response of Non-Small Cell Lung Cancer with AzacytidineJohn Wrangle, Wei Wang, Alexander Koch, et al.
Rheumatology (Oxford, England)|January 9, 2024
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patientsConor Coyle, Lily Watson, Caroline Whately-Smith, et al.
Nature|July 11, 2023
De novo design of protein structure and function with RFdiffusionJoseph L Watson, David Juergens, Nathaniel R Bennett, et al.
Rheumatology (Oxford, England)|November 27, 2023
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritisLily Watson, Conor Coyle, Caroline Whately-Smith, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
<i>De novo</i> design of phospho-tyrosine peptide bindersMagnus S Bauer, Jason Z Zhang, Kejia Wu, et al.
The New England Journal of Medicine|June 22, 2017
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung CancerDavid P Carbone, Martin Reck, Luis Paz-Ares, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 24, 2022
On the Current Care Situation and Treatment of Ocular Mucous Membrane Pemphigoid in GermanyRémi Yaïci, Mathias Roth, Lukas Juergens, et al.
Nature|December 18, 2023
De novo design of high-affinity binders of bioactive helical peptidesSusana Vázquez Torres, Philip J Y Leung, Preetham Venkatesh, et al.
The European Respiratory Journal|July 30, 2021
COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapyMarkus Weckmann, Thomas Bahmer, Jannie Marie Sand, et al.
JAMA|October 10, 2023
Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical TrialSusan S Huang, Edward J Septimus, Ken Kleinman, et al.
Pageof 67

Showing results (641-650 of 662) with videos related to

Sort By:
Pageof 67
Oncotarget|October 29, 2013
Alterations of immune response of Non-Small Cell Lung Cancer with AzacytidineJohn Wrangle, Wei Wang, Alexander Koch, et al.
Rheumatology (Oxford, England)|January 9, 2024
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patientsConor Coyle, Lily Watson, Caroline Whately-Smith, et al.
Nature|July 11, 2023
De novo design of protein structure and function with RFdiffusionJoseph L Watson, David Juergens, Nathaniel R Bennett, et al.
Rheumatology (Oxford, England)|November 27, 2023
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritisLily Watson, Conor Coyle, Caroline Whately-Smith, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
<i>De novo</i> design of phospho-tyrosine peptide bindersMagnus S Bauer, Jason Z Zhang, Kejia Wu, et al.
The New England Journal of Medicine|June 22, 2017
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung CancerDavid P Carbone, Martin Reck, Luis Paz-Ares, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 24, 2022
On the Current Care Situation and Treatment of Ocular Mucous Membrane Pemphigoid in GermanyRémi Yaïci, Mathias Roth, Lukas Juergens, et al.
Nature|December 18, 2023
De novo design of high-affinity binders of bioactive helical peptidesSusana Vázquez Torres, Philip J Y Leung, Preetham Venkatesh, et al.
The European Respiratory Journal|July 30, 2021
COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapyMarkus Weckmann, Thomas Bahmer, Jannie Marie Sand, et al.
JAMA|October 10, 2023
Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical TrialSusan S Huang, Edward J Septimus, Ken Kleinman, et al.
Pageof 67